Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation.
Ontology highlight
ABSTRACT: BACKGROUND: Protein disulfide isomerase (PDI) is required for thrombus formation. We previously demonstrated that glycosylated quercetin flavonoids such as isoquercetin inhibit PDI activity and thrombus formation in animal models, but whether extracellular PDI represents a viable anticoagulant target in humans and how its inhibition affects blood coagulation remain unknown. METHODS: We evaluated effects of oral administration of isoquercetin on platelet-dependent thrombin generation in healthy subjects and patients with persistently elevated anti-phospholipid antibodies. RESULTS: Following oral administration of 1,000 mg isoquercetin to healthy adults, the measured peak plasma quercetin concentration (9.2 μM) exceeded its IC50 for inhibition of PDI by isoque
SUBMITTER: Stopa JD
PROVIDER: S-EPMC5214567 | biostudies-literature | 2017 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA